Hints and tips:
Related Special Reports
...It has also worked on drug development for US pharma company Johnson & Johnson, Danish biotech group Genmab and British biotech Iksuda therapeutics....
...Lars Fruergaard Jørgensen, chief executive of Novo Nordisk, Europe’s largest pharma group by market capitalisation, was paid DKr68mn (£7.8mn) last year....
...State-backed brokerages dominate China’s vast financial markets, where western investment banks have made limited inroads in recent years and returns have disappointed at a time of weak economic momentum...
...“Investments in life sciences are taking place in the US and, as a consequence, lots of the talent is based in the US.”...
...Under the commission’s proposed new pharma plans, which are still under discussion and have not yet become law, manufacturers would be required to market new drugs in all 27 EU countries within two years...
...“The company has been actively working together with its advisers to set the record straight and advocate for changes to the proposed legislation,” Edward Hu, vice-chair and chief investment officer, said...
...The approval of Madrigal’s drug should help other treatments to pass regulatory hurdles, according to analysts at investment bank William Blair....
...But don’t assume that these burgeoning product lines will be healthy investment options, nor that they are necessarily terribly sustainable. Read it here....
...“I’d put Vertex in my pharma top three [to invest in].” This year, Vertex’s market capitalisation surpassed $100bn for the first time....
...As healthcare systems around the world put pressure on drug prices, pharma companies are also looking for ways to cut costs in research and development....
...But leading shareholders welcomed the pay rise before the vote, with Rajiv Jain, chief investment officer at top-20 shareholder GQG Partners, saying Soriot was “massively underpaid” given the performance...
...“[This means] the return on investment for antibacterials is much lower than other types of drug development.”...
...Adrian Frost, an investment manager at Artemis Fund Managers, a top-20 shareholder, said the bid price was “way off”....
...However, Markus Manns, a portfolio manager at Germany’s third largest asset manager Union Investment, was more upbeat....
...The biotech group’s investors for this funding round include MSD GHIF, an investment arm of US pharma company MSD, along with UK venture capital group IQ Capital....
...Chief executive George Weston said the performance was driven by investments in the company over the past few years such as opening new stores or automating some warehouses, and profit margins “recovering...
...Voya Investment Management has also hired Eric Stein as its head of investments and chief investment officer of fixed income. Stein joins from Morgan Stanley Investment Management....
...Astellas Pharma bought eye-treatment specialist Iveric Bio in a $5.9bn deal in May. Mizuho splashed out $550mn for US boutique investment bank Greenhill & Co....
...Its £1bn investment trust also had a tough 2023, with the trust’s managers noting that last year was “the worst in the history of Ruffer Investment Company”....
...The pharma group’s investment-grade debt sale, which has not yet priced, will span eight or nine maturity brackets from two to 40 years....
...That push would provide a welcome boost for the biggest local biotech and pharma groups, including Jiangsu Hengrui, WuXi Biologics, Shanghai Fosun Pharma and Sinopharm....
...In recent years, the university town’s technology and life sciences industry scene has been attracting record investment, talent — and homebuyers....
...The pharma group said drugs developed by its legacy companies helped to form the “building blocks” of today’s GSK....
...Anglo, whose largest investor is South African state entity Public Investment Corporation, on Friday rejected BHP’s offer as “highly unattractive”. BHP has until May 22 to submit a formal bid....
...Investors should be asking what distinguishes private equity from other, more traditional, investment strategies....
International Edition